Repurposing an anti‐cancer agent for the treatment of hypertrophic heart disease

Coronary microvascular dysfunction combined with maladaptive cardiomyocyte morphology and energetics is a major contributor to heart failure advancement. Thus, dually enhancing cardiac angiogenesis and targeting cardiomyocyte function to slow, or reverse, the development of heart failure is a logica...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Pathol
Autors principals: Dukinfield, Matthew, Maniati, Eleni, Reynolds, Louise E, Aubdool, Aisah, Baliga, Reshma S, D'Amico, Gabriela, Maiques, Oscar, Wang, Jun, Bedi, Kenneth C, Margulies, Kenneth B, Sanz‐Moreno, Victoria, Hobbs, Adrian, Hodivala‐Dilke, Kairbaan
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2019
Matèries:
Original Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900130/
https://ncbi.nlm.nih.gov/pubmed/31424556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.5340
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars